Buscar por Autor Sánchez del Campo Ferrer, Luis

Ir a una fecha de inicio:
Mostrando resultados 1 a 20 de 27  Siguiente >
Vista previaFecha de publicaciónFecha de CreaciónTítulo
31-ago-20052005Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice
International journal B&CB - 2007 - Navarro-Peran.pdf.jpg2007-Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate
JMEDCHEM-TMECG 2008.pdf.jpg10-abr-2008-Synthesis and Biological Activity of a 3,4,5-Trimethoxybenzoyl Ester Analogue of Epicatechin-3-gallate
Int J cancer 2008.pdf.jpg15-nov-2008-Targeting the methionine cycle for melanoma therapy with 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin
book.png2009-Diseño, síntesis y actividad antitumoral de un inhibidor de la dihidrofolato reductasa, derivado de las catequinas del té, para el tratamiento del melanoma / Luis Sánchez del Campo Ferrer; director José Neptuno Rodríguez López.
Pigment Cell 2009.pdf.jpg10-ene-2009-The critical role of alpha-folate receptor in the resistance of melanoma to methotrexate
Mol Pharm Melanoma 2009.pdf.jpg9-abr-2009-Melanoma Activation of 3-O-(3,4,5-Trimethoxybenzoyl)-(-)-Epicatechin to a Potent Irreversible Inhibitor of Dihydrofolate Reductase
ijms 2009.pdf.jpg18-dic-2009-Binding of Natural and Synthetic Polyphenols to Human Dihydrofolate Reductase
J cell biochem 2010.pdf.jpg1-jun-2010-Mechanism of Dihydrofolate Reductase Downregulation in Melanoma by 3-O-(3,4,5-Trimethoxybenzoyl)-(-)-Epicatechin
Chemdechem 2011.pdf.jpg7-mar-2011-Comparison of a Pair of Synthetic Tea-Catechin-Derived Epimers: Synthesis, Antifolate Activity, and Tyrosinase-Mediated Activation in Melanoma
1-s2.0-S1535610813002365-main.pdf.jpg20-jun-2013-Directed Phenotype Switching as an Effective Antimelanoma Strategy
sacilotto-et-al-2013-analysis-of-dll4-regulation-reveals-a-combinatorial-role-for-sox-and-notch-in-arterial-development.pdf.jpg1-jul-2013-Analysis of Dll4 regulation reveals a combinatorial rolefor Sox and Notch in arterial development
Oncogene review intr.pdf.jpg27-ene-2014-Targeting the epigenetic machinery of cancer cells
1-s2.0-S1476558613800760-main.pdf.jpg28-feb-2014-Suppression of antifolate resistance by targeting the myosin va trafficking pathway in melanoma
PCMRUllrichetal binder.pdf.jpgnov-2015-MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma
TD_CD_compendio_MPFP.pdf.jpg10-dic-20154-dic-2015Bases moleculares de la resistencia del melanoma a los antifolatos: diseño de nuevas estrategias terapéuticas
Oncogene 2016 intro.pdf.jpg2-may-2016-Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis
toxins-08-00206.pdf.jpg5-jul-2016-Lebein, a snake venom disintegrin, induces apoptosis in human melanoma cells
18.pdf.jpg17-ene-2017-Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
Sci Reports 2020.pdf.jpg6-ago-2020-PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation